rPA reteplase data

Preliminary data from the first 280 patients enrolled in Boehringer's 324-patient RAPID 2 trial showed statistically significant improvement of the German company's drug over GNE's tPA in the numbers of open heart

Read the full 327 word article

How to gain access

Continue reading with a
two-week free trial.